West Lafayette-based Inotiv Inc. is reporting a fiscal full-year net loss of $68.6 million, compared to a loss of $108.4 million the previous year. The pharmaceutical testing company said the improvement is largely due to a 4.5% increase in total revenue.... Read More
The CEO of the Indiana University Launch Accelerator for Biosciences, or IU LAB, in Indianapolis says the recently announced $40 million agreement between IU and Eli Lilly and Co. represents a new day for the university.... Read More
Eli Lilly and Co. and Indiana University have announced a new agreement that would see the company to provide up to $40 million over five years to the university to bolster clinical trials and enhance care and research focused on Alzheimer’s disease.... Read More
The Indianapolis drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers and others covered by their health plans.... Read More
Indianapolis-based Eli Lilly and Co., the world’s largest drugmaker, just notched another milestone: It’s the first health care company to cross the $1 trillion threshold as investors bet big on the drugmaker’s weight-loss medicines.... Read More
Eli Lilly and Co. said Wednesday it plans to open a new Lilly Gateway Labs site in Philadelphia, part of a broader effort to help foster biotech startups and innovations.... Read More
The medical device manufacturer says the ROSA Knee with OptimiZe system provides a more customized experience for surgeons performing robotic-assisted total knee replacement surgery.... Read More
Roche Diagnostics in Indianapolis is preparing to launch the first Alzheimer's blood-based test in the world designed for the primary care setting.... Read More
Supporters say the pieces are falling into place along the banks of the White River in downtown Indianapolis—70 acres at the former GM Stamping Plant site that could position the crossroads of America into the crossroads of bioscience innovation.... Read More
Since its founding in 2007, the Susan G. Komen Tissue Bank at IU’s Melvin and Bren Simon Comprehensive Cancer Center has collected healthy breast tissue from more than 5,600 women. In 2023, the tissue bank began collecting tissue donations from men.... Read More
The Heartland BioWorks Tech Hub has signed an agreement with the National Institute for Bioprocessing Research and Training, or NIBRT, to fuel biomanufacturing workforce development efforts in Indiana.... Read More
The event, being held at the recently opened Elanco Animal Health global headquarters in downtown Indianapolis, brings together more than 250 leaders to discuss "the most pressing challenges and emerging opportunities" in the life sciences industry.... Read More
The clinical trial, announced last month, focuses on Beverly, Massachusetts-based Akston Bioscience Corp.’s Ambifect immune-enhancing therapy, with Purdue researchers looking to enroll about 10 dogs.... Read More
Fort Wayne-based orthopedic device maker BioPoly LLC has added another innovation to its list of patents, this one a shoulder implant for people who suffer frequent dislocations.... Read More
President Donald Trump unveiled a deal Thursday with drugmakers Indianapolis-based Eli Lilly and Co. and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.... Read More
Despite a dip in profit, Warsaw-based medical device manufacturer Zimmer Biomet said it topped $2 billion in sales for the third quarter, marking a 9.7% year-over-year increase.... Read More
The White House is expected to announce a deal this week with Indianapolis-based Eli Lilly and Co. and with Novo Nordisk that would lower the price of their popular obesity drugs to $149 per month in some cases.... Read More
Indianapolis-based Eli Lilly and Co. announced Monday that it plans to build a $3 billion manufacturing site in the Netherlands to produce oral medications, including its highly anticipated GLP-1 pill for weight loss, orforglipron.... Read More
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.... Read More
Indianapolis-based drug maker Eli Lilly and Co. on Wednesday announced it plans to spend more than $1.2 billion to expand and update its manufacturing site in Puerto Rico to increase production of oral medications, including its highly anticipated GLP-1 pill.... Read More
